Sorrento Therapeutics Funding & Investors
Sorrento Therapeutics, Inc. is a biopharmaceutical company. The Company researches human therapeutic antibodies for the treatment of cancer, inflammation, metabolic, and infectious diseases.
sorrentotherapeutics.comTotal Amount Raised: $150,000,000
Sorrento Therapeutics Funding Rounds
Post Ipo Equity
$150,000,000
Post Ipo Equity Investors
Ally Bridge Group
Funding info provided by Diffbot.